Medidata Solutions, Inc. (NASDAQ:MDSO) will be issuing its quarterly earnings data before the market opens on Monday, October 23rd. Analysts expect the company to announce earnings of $0.31 per share for the quarter.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.28 by $0.03. The firm had revenue of $137.41 million for the quarter, compared to analyst estimates of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The business’s revenue for the quarter was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.24 EPS. On average, analysts expect Medidata Solutions to post $0.78 EPS for the current fiscal year and $1.01 EPS for the next fiscal year.

Shares of Medidata Solutions, Inc. (NASDAQ MDSO) opened at 80.01 on Monday. Medidata Solutions, Inc. has a 52-week low of $46.10 and a 52-week high of $85.92. The stock’s 50 day moving average is $76.67 and its 200 day moving average is $73.20. The stock has a market cap of $4.53 billion, a price-to-earnings ratio of 129.26 and a beta of 1.77.

In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total transaction of $372,650.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 5.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Medidata Solutions, Inc. (MDSO) Scheduled to Post Quarterly Earnings on Monday” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at

A number of analysts recently issued reports on MDSO shares. Citigroup Inc. restated a “buy” rating and set a $95.00 target price (up previously from $94.00) on shares of Medidata Solutions in a research report on Monday, July 24th. Needham & Company LLC restated a “buy” rating and set a $90.00 target price (up previously from $75.00) on shares of Medidata Solutions in a research report on Friday, July 21st. SunTrust Banks, Inc. raised their target price on shares of Medidata Solutions from $80.00 to $90.00 and gave the stock a “buy” rating in a research report on Tuesday, June 27th. BidaskClub upgraded shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research report on Wednesday, June 21st. Finally, KeyCorp restated a “buy” rating and set a $86.00 target price on shares of Medidata Solutions in a research report on Sunday, September 17th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $84.64.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Earnings History for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with's FREE daily email newsletter.